Skip to main content

Table 3 Drug therapy of newly-diagnosed dementia patients by the family practitioner

From: Effects of general practitioner training and family support services on the care of home-dwelling dementia patients - Results of a controlled cluster-randomized study

First diagnoses A (n = 48) B (n = 41) C (n = 32) p-value* Adjusted p-value
   Prescription of specific anti-dementia drug (independent of guideline)§ 14 (29.2%) 15 (36.6%) 12 (37.5%) .6711 .857
First diagnoses with purely vascular dementia A (n = 10) B (n = 10) C (n = 10)   
   No cholinesterase inhibitor/Memantine in purely vascular dementia (in conformity with guideline) 4 (40.0%) 7 (70.0%) 9 (90.0%) .0582 .071
First diagnoses with mild dementia with specific anti-dementia treatment A (n = 11) B (n = 12) C (n = 9)   
   No Memantine in mild dementia (in conformity with guideline) 6 (54.5%) 10 (83.3%) 6 (66.7%) .3263 .477
  1. § cholinesterase inhibitor/Memantine
  2. * Chi²-Test
  3. 1 Chi² (2) = .797
  4. 2 Chi² (2) = 5.700
  5. 3 Chi² (2) = 2.239
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us